Point72 Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $18.8M | Sell |
515,968
-460,084
| -47% | -$16.7M | 0.04% | 439 |
|
2025
Q1 | $35.3M | Sell |
976,052
-206,825
| -17% | -$7.49M | 0.08% | 272 |
|
2024
Q4 | $49.8M | Buy |
1,182,877
+529,217
| +81% | +$22.3M | 0.11% | 204 |
|
2024
Q3 | $36.3M | Buy |
653,660
+113,911
| +21% | +$6.33M | 0.09% | 237 |
|
2024
Q2 | $22.2M | Buy |
539,749
+478,849
| +786% | +$19.7M | 0.06% | 336 |
|
2024
Q1 | $2.84M | Sell |
60,900
-41,600
| -41% | -$1.94M | 0.01% | 817 |
|
2023
Q4 | $4.9M | Sell |
102,500
-613,962
| -86% | -$29.4M | 0.01% | 732 |
|
2023
Q3 | $25.5M | Buy |
716,462
+291,588
| +69% | +$10.4M | 0.07% | 311 |
|
2023
Q2 | $19.6M | Sell |
424,874
-961,987
| -69% | -$44.4M | 0.06% | 358 |
|
2023
Q1 | $55.6M | Buy |
1,386,861
+659,174
| +91% | +$26.4M | 0.17% | 144 |
|
2022
Q4 | $33.7M | Buy |
727,687
+377,000
| +108% | +$17.5M | 0.11% | 219 |
|
2022
Q3 | $14.5M | Buy |
350,687
+77,172
| +28% | +$3.2M | 0.06% | 386 |
|
2022
Q2 | $16.3M | Sell |
273,515
-44,982
| -14% | -$2.68M | 0.07% | 345 |
|
2022
Q1 | $23.1M | Sell |
318,497
-107,377
| -25% | -$7.8M | 0.09% | 269 |
|
2021
Q4 | $35.8M | Buy |
425,874
+85,500
| +25% | +$7.19M | 0.14% | 191 |
|
2021
Q3 | $30.7M | Sell |
340,374
-366,926
| -52% | -$33.1M | 0.13% | 195 |
|
2021
Q2 | $67.4M | Buy |
707,300
+587,700
| +491% | +$56M | 0.3% | 69 |
|
2021
Q1 | $13.6M | Sell |
119,600
-100
| -0.1% | -$11.4K | 0.06% | 340 |
|
2020
Q4 | $16.6M | Buy |
+119,700
| New | +$16.6M | 0.08% | 305 |
|
2020
Q1 | – | Sell |
-117,496
| Closed | -$5.02M | – | 986 |
|
2019
Q4 | $5.02M | Buy |
117,496
+61,680
| +111% | +$2.63M | 0.03% | 465 |
|
2019
Q3 | $2.39M | Buy |
55,816
+21,553
| +63% | +$922K | 0.01% | 521 |
|
2019
Q2 | $2.18M | Buy |
+34,263
| New | +$2.18M | 0.01% | 562 |
|
2019
Q1 | – | Sell |
-173,700
| Closed | -$7.55M | – | 1072 |
|
2018
Q4 | $7.55M | Buy |
173,700
+138,700
| +396% | +$6.03M | 0.04% | 401 |
|
2018
Q3 | $2.67M | Sell |
35,000
-25,000
| -42% | -$1.91M | 0.01% | 581 |
|
2018
Q2 | $4.61M | Sell |
60,000
-10,000
| -14% | -$769K | 0.02% | 501 |
|
2018
Q1 | $3.57M | Sell |
70,000
-23,400
| -25% | -$1.19M | 0.01% | 518 |
|
2017
Q4 | $4.33M | Buy |
93,400
+43,400
| +87% | +$2.01M | 0.02% | 509 |
|
2017
Q3 | $2.66M | Sell |
50,000
-15,000
| -23% | -$799K | 0.01% | 528 |
|
2017
Q2 | $4.04M | Sell |
65,000
-15,000
| -19% | -$932K | 0.02% | 463 |
|
2017
Q1 | $5.42M | Buy |
+80,000
| New | +$5.42M | 0.03% | 465 |
|